DE3483402D1 - Imidazolidinedion-derivate. - Google Patents

Imidazolidinedion-derivate.

Info

Publication number
DE3483402D1
DE3483402D1 DE8484303420T DE3483402T DE3483402D1 DE 3483402 D1 DE3483402 D1 DE 3483402D1 DE 8484303420 T DE8484303420 T DE 8484303420T DE 3483402 T DE3483402 T DE 3483402T DE 3483402 D1 DE3483402 D1 DE 3483402D1
Authority
DE
Germany
Prior art keywords
spiro
trione
imidazolidine
indoline
pyridylmethyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE8484303420T
Other languages
German (de)
English (en)
Inventor
Alan Jeffrey Hutchison
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc filed Critical Pfizer Inc
Application granted granted Critical
Publication of DE3483402D1 publication Critical patent/DE3483402D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/10—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Biomedical Technology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Cosmetics (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • External Artificial Organs (AREA)
  • Fats And Perfumes (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE8484303420T 1983-05-25 1984-05-21 Imidazolidinedion-derivate. Expired - Lifetime DE3483402D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/497,962 US4464380A (en) 1983-05-25 1983-05-25 Imidazolidinedione derivatives

Publications (1)

Publication Number Publication Date
DE3483402D1 true DE3483402D1 (de) 1990-11-22

Family

ID=23979057

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8484303420T Expired - Lifetime DE3483402D1 (de) 1983-05-25 1984-05-21 Imidazolidinedion-derivate.

Country Status (19)

Country Link
US (1) US4464380A (enExample)
EP (1) EP0127412B1 (enExample)
JP (1) JPS604183A (enExample)
KR (1) KR860001869B1 (enExample)
AT (1) ATE57531T1 (enExample)
AU (1) AU543916B2 (enExample)
CA (1) CA1266270A (enExample)
DE (1) DE3483402D1 (enExample)
DK (1) DK163924C (enExample)
ES (2) ES8600764A1 (enExample)
FI (1) FI78699C (enExample)
GR (1) GR82020B (enExample)
HU (1) HU190548B (enExample)
IE (1) IE57520B1 (enExample)
IL (1) IL71904A (enExample)
PH (1) PH21151A (enExample)
PL (3) PL143070B1 (enExample)
PT (1) PT78625A (enExample)
YU (2) YU43931B (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE37371T1 (de) * 1984-08-20 1988-10-15 Pfizer Verfahren zur herstellung asymmetrischer hydantoine.
US4762839A (en) * 1985-06-06 1988-08-09 Tanabe Seiyaku Co., Ltd. Quinazolinone copmpounds useful for the prophyloxis and treatment of diabetic complications
JPS63132889A (ja) * 1986-11-21 1988-06-04 Tanabe Seiyaku Co Ltd キナゾリノン誘導体
US4841079A (en) * 1987-08-07 1989-06-20 Pfizer, Inc. Process for the production of asymmetric hydantoins
ES2187603T3 (es) * 1995-10-18 2003-06-16 Hoffmann La Roche Hidroximetilacion de tocoferoles.
BR9916371A (pt) 1998-12-19 2001-09-18 Janssen Pharmaceutica Nv Composto de espiro anti-histamìnico
WO2007091948A2 (en) * 2006-02-07 2007-08-16 Astrazeneca Ab Novel spiro [imidazolidine-4, 3´-indole] 2, 2´,5´(1h) triones for treatment of conditions associated with vanilloid receptor 1

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3821383A (en) * 1972-07-10 1974-06-28 Ayerst Mckenna & Harrison Compositions for and a method of treating diabetic complications
US4200642A (en) * 1978-08-21 1980-04-29 Pfizer Inc. Spiro-oxazolidindiones
US4490381A (en) * 1979-11-13 1984-12-25 Imperial Chemical Industries Plc 1'-Substituted spiro[imidazolidine-4,3'-indoline]2,2',5-triones
ZA806623B (en) * 1979-11-13 1981-12-30 Ici Ltd Substituted indoline-2-one derivatives
US4248882A (en) * 1980-02-12 1981-02-03 Pfizer Inc. Treating diabetes-associated complications with hydantoin amines
IE52879B1 (en) * 1981-05-12 1988-03-30 Ici Plc Pharmaceutical spiro-hydantoin derivatives

Also Published As

Publication number Publication date
KR860001869B1 (ko) 1986-10-24
US4464380A (en) 1984-08-07
YU212286A (en) 1987-10-31
EP0127412A3 (en) 1987-09-02
AU543916B2 (en) 1985-05-09
ES532736A0 (es) 1985-10-16
YU43958B (en) 1989-12-31
DK250084D0 (da) 1984-05-22
HUT34194A (en) 1985-02-28
FI842079A0 (fi) 1984-05-24
YU89784A (en) 1987-04-30
ES8607304A1 (es) 1986-06-01
IL71904A (en) 1988-01-31
ATE57531T1 (de) 1990-11-15
JPS604183A (ja) 1985-01-10
JPH0573754B2 (enExample) 1993-10-15
ES8600764A1 (es) 1985-10-16
PL247804A1 (en) 1985-08-13
EP0127412B1 (en) 1990-10-17
AU2856384A (en) 1984-11-29
HU190548B (en) 1986-09-29
KR840009101A (ko) 1984-12-24
DK163924C (da) 1992-09-14
FI78699C (fi) 1989-09-11
IE841294L (en) 1984-11-25
DK163924B (da) 1992-04-21
YU43931B (en) 1989-12-31
PL143290B1 (en) 1988-02-29
EP0127412A2 (en) 1984-12-05
IE57520B1 (en) 1993-05-19
PL252850A1 (en) 1985-11-19
IL71904A0 (en) 1984-09-30
GR82020B (enExample) 1984-12-12
DK250084A (da) 1984-11-26
CA1266270A (en) 1990-02-27
FI842079A7 (fi) 1984-11-26
PT78625A (en) 1984-06-01
FI78699B (fi) 1989-05-31
ES540858A0 (es) 1986-06-01
PH21151A (en) 1987-07-30
PL143070B1 (en) 1988-01-30

Similar Documents

Publication Publication Date Title
NO162764C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive indolinderivater.
HU907025D0 (en) Process for producing substituted n-(imidazolyl-alkyl)-alanine derivatives and pharmaceutical preparatives containing these compounds as active substance
AU543916B2 (en) Spiro(imidazolidine-indolines) and spiro (imidazolidine- azaindolines)
ATE3865T1 (de) Hydantoinamine und deren pharmazeutische zusammensetzungen.
NO893909D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive imidazol-derivater.
IE851155L (en) Benzo-(pyrano and thiopyrano)-pyridines
ATE80616T1 (de) Prostaglandin e1-derivate und ihre therapeutische anwendung.
IL76345A0 (en) Proline derivatives and antihypertensive and anti-glaucoma pharmaceutical preparations containing the same
IE800109L (en) Spiro-quinolylhydantoins
MY101896A (en) New tetracyclic indole derivatives
IE800672L (en) Spiro-quinolone hydantoins
HUT44769A (en) Process for producing spiro/benzofuran-2(3h),1'-cycloheptane/ derivatives and pharmaceutical preparations comprising these compounds
NO890328L (no) Fremgangsmaate for fremstilling av terapeutisk aktive 4-amino-2,3-disubstituert-6,7-dihydro-5h-1-pyrindinderivater.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee